Background: We present a case report of a 24 year-old male who presented with encephalopathy, rigidity, and hyperthermia after receiving his medication. In this report, we guide you through the approach, differential diagnosis, investigation, and treatment modalities for similar presentations.
GurreraRCaroffSCohenA, et al.An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72(9):1222-1228.
2.
PileggiDCookA. Neuroleptic malignant syndrome. Ann Pharmacother. 2016;50(11):973-981.
3.
KuhlwilmLSchönfeldt-LecuonaCGahrMConnemannBJKellerFSartoriusA. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome. Acta Psychiatr Scand. 2020;142(3):233-241.
4.
MorcosNRosinskiAMaixnerD. Electroconvulsive therapy for neuroleptic malignant syndrome: a case series. J ECT. 2019;35(4):225-230.
5.
WareMFellerDHallK. Neuroleptic malignant syndrome: diagnosis and management. Prim Care Companion CNS Disord. 2018;20(0):17r02185.
6.
WellsASommiRCrismonM. Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intell Clin Pharm. 1988;22(6):475-480.
7.
TseLBarrAScarapicchiaVVila-RodriguezF. Neuroleptic malignant syndrome: a review from a clinically oriented perspective. Curr Neuropharmacol. 2015;13(3):395-406.
8.
RosebushPStewartT. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry. 1989;146(6):717-725.
9.
RosenbergMGreenM. Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med. 1989;149(9):1927-1931.
10.
RosebushPStewartTMazurekM. The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?Br J Psychiatry. 1991;159:709-712.
11.
GuinartDMisawaFRubioJ, et al.Outcomes of neuroleptic malignant syndrome with depot versus oral antipsychotics: a systematic review and pooled, patient-level analysis of 662 case reports. J Clin Psychiatry. 2020;82(1):20r13272.
12.
VirolleJRedonMMontastrucF, et al.What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: a systematic review. Schizophr Res. 2023;262:184-200.
13.
RogersJOldhamMFricchioneG, et al.Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2023;37(4):327-369.
14.
MoshfeghiniaRHosseinzadehMMostafaviS, et al.Recurrent cannabis-induced catatonia: a case report and comprehensive systematic literature review. Front Psychiatry. 2024;15:1332310.
15.
MannSCCaroffSNBleierHRWelzWKKlingMAHayashidaM. Lethal catatonia. Am J Psychiatry. 1986;143(11):1374-1381.
